Discontinued ProductBTCP maleate (Cat. No. 0702) has been withdrawn from sale for commercial reasons.
A potent dopamine re-uptake inhibitor with a behavioral profile different from that of PCP and similar to that of cocaine.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Chergui et al (1992) Inhibition of the locus coeruleus neurons by the phenylcyclidine analog, N-[1-(2-benzo(b thiophenyl)cyclohexyl]-piperidine: evidence for potent indirect adrenoceptor agonist properties. Eur.J.Pharmacol. 219 169 PMID: 1397045
Koek et al (1989) The phencyclidine (PCP) analogue N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioural effects with PCP, ketamine and MK-801. J.Pharmacol.Exp.Ther. 250 1019 PMID: 2674416
Vignon et al (1988) [3H]N-[1-(2-benzo[b]thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analogue selective for the dopamine uptake complex. Eur.J.Pharmacol. 148 427 PMID: 3384005
View Related Products by Product Action
Keywords: BTCP maleate, BTCP maleate supplier, Potent, dopamine, reuptake, inhibitors, inhibits, DAT, Transporters, Monoamine, Neurotransmitter, Dopamine, 0702, Tocris Bioscience
Citations for BTCP maleate
Citations are publications that use Tocris products.
Currently there are no citations for BTCP maleate.
Reviews for BTCP maleate
There are currently no reviews for this product. Be the first to review BTCP maleate and earn rewards!
Have you used BTCP maleate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Dopamine Receptors Scientific Review
Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.
The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.